MS patients are three to six times more likely to develop seizures. Using a mouse model, a team of scientists has found for the first time that chronic demyelination is closely linked to, and is likely the cause of, these seizures. A new study could lead to the development of drugs aimed at reducing seizures in multiple sclerosis, potentially benefiting epilepsy patients as well.